Incubation Periods and Monitoring Duration for Infectious Agents
COVID-19 (SARS-CoV-2)
The incubation period for COVID-19 ranges from 1 to 14 days, with a median of approximately 5 days, and a 14-day monitoring period is recommended for close contacts and exposed individuals. 1, 2
Key Incubation Period Data
- Median incubation period: 5.1 days (95% CI: 4.5-5.8 days), with 97.5% of individuals developing symptoms within 11.5 days of infection 2
- The most common range is 3 to 7 days from exposure to symptom onset 1
- Approximately 101 out of every 10,000 cases will develop symptoms after 14 days of monitoring under conservative assumptions 2
- Alternative estimates from different populations show a median of 3 days (95% CI: 0.6-8.2 days) 3
Monitoring Recommendations
- 14-day health observation period is recommended for all close contacts and persons with suspicious exposure, starting from the last day of contact with infected patients 1
- Individuals should immediately seek medical attention if they develop fever, respiratory symptoms (coughing, shortness of breath), or diarrhea during the monitoring period 1
- The incubation period of approximately 4 days was initially reported, with studies suggesting a range of 2 to 14 days 1
Clinical Progression Timeline
- Mean time from symptom onset to seeking medical advice: 5.8 days 1
- Mean time from symptom onset to hospital admission: 12.5 days 1
- Disease stages based on CT findings: early (0-4 days), progressive (5-8 days), peak (9-13 days), and absorption (≥14 days) 1
Hepatitis A
Hepatitis A has an incubation period of approximately 4 weeks (28 days) from exposure to symptom onset. 1
- Post-exposure prophylaxis with immune globulin should be administered as soon as possible, but no more than 2 weeks after exposure 1
- The fecal-oral route is the primary mode of transmission 1
Hepatitis B
Hepatitis B has an incubation period ranging from 6 weeks to 6 months from exposure to symptom onset. 1
- Contacts should receive vaccination and post-exposure prophylaxis promptly after identified exposure 1
- Sexual transmission accounts for most HBV infections in adults in the United States 1
Influenza A (H7N9)
The median incubation period for human-to-human transmitted influenza A(H7N9) is 4 days, with a serial interval of 9 days. 4
- China's 10-day monitoring period for close contacts should detect most secondary infections 4
General Respiratory Viral Infections
Based on systematic review of respiratory viral pathogens 5:
- Adenovirus: 5.6 days (95% CI: 4.8-6.3)
- Human coronavirus: 3.2 days (95% CI: 2.8-3.7)
- Influenza A: 1.4 days (95% CI: 1.3-1.5)
- Influenza B: 0.6 days (95% CI: 0.5-0.6)
- Measles: 12.5 days (95% CI: 11.8-13.3)
- Parainfluenza: 2.6 days (95% CI: 2.1-3.1)
- Respiratory syncytial virus: 4.4 days (95% CI: 3.9-4.9)
- Rhinovirus: 1.9 days (95% CI: 1.4-2.4)
Hand, Foot, and Mouth Disease
Peak infectiousness occurs during the first week of illness, particularly from 1 day before symptoms through 5-7 days after symptom onset. 6
Monitoring and Exclusion Recommendations
- Children should be excluded from childcare and school for 10-14 days from symptom onset 6
- Very young children can shed virus for up to 6 days before illness onset 6
- Rigorous handwashing is essential during the entire infectious window 6
Tuberculosis
For tuberculosis contact investigations, the period of infectiousness is typically assumed to begin approximately 3 months before diagnosis, though it may be longer depending on symptom history. 1
- The end of infectiousness is defined when contact is broken or when specific criteria for non-infectiousness during therapy are met 1
- Patients with multidrug-resistant TB on inadequate therapy may remain infectious for prolonged periods 1
Important Caveats
- Right tail considerations: When establishing quarantine policy, consider the full distribution of the incubation period, particularly the 95th-99th percentiles, as some individuals will fall outside the median range 2, 5
- Asymptomatic transmission: For COVID-19, infected individuals can transmit the virus even when asymptomatic or presymptomatic, possessing the same viral load as symptomatic patients 1
- Population variations: Incubation periods may vary based on age, immune status, and viral load at exposure 1